Drug Information Association Logo

INNOVATION IN CLINICAL TRIAL DESIGN AND EVALUATION

Track:
Innovation in R&D Models

Day & Time:
March 26, 4:00PM - 5:30PM (Central European Standard Time)

Session Number:
1404

Room Number:
Room NO

Type:
Session

Title:
INNOVATION IN CLINICAL TRIAL DESIGN AND EVALUATION

Chair(s):
Martin Siman, PhD, MBA
Director, Design and Interpretation Centre of Excellence
AstraZeneca, Sweden

Description:
Research on clinical trial design and evaluation needs to be so seamlessly woven into clinical practice, that the delivery of care also is generating new knowledge and thus enables innovation. Clinical research will be addressed from the perspective of enhancing study design methodologies and transparency combined with a continuous learning loop to provide the best personalized patient care possible.

Presentation(s) & Speaker(s):
The IMI GetReal Consortium: Developing relative effectiveness estimates for medicines in development
Sarah Garner
Associate Director - Research & Development
National Institute for Health and Care Excellence (NICE), United Kingdom

Predictive analytic modelling operational characteristics at design and monitoring clinical trials
Vladimir V Anisimov, DrSc, PhD
Senior Strategic Biostatistics Director
Quintiles, United Kingdom

Common Study Design Language/Syntax
Norbert Bleich
F. Hoffmann-La Roche, Switzerland

Gathering and Leveraging Quality-Centric Metadata in Clinical Trials
Aaron Gadberry
Director, Software Architecture
DATATRAK, United States